EP2596363
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.7.2011EP published:
18.1.2017EP application number:
11746191.3
EPO information:
European Patent Register
Max expiry date:
17.7.2031
Title:
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER
Timeline
Today
18.7.2011EP application
18.1.2017EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070, Basel, CH
Inventor
Name:
DE HAAS, Sanne LysbetAddress:
Basel, CH
Name:
DELMAR, PaulAddress:
Basel, CH
Name:
FOERNZLER, DorotheeAddress:
Lenzburg, CH
Name:
KLAUSE, UrsulaAddress:
Peissenberg, DE
Name:
SCHERER, StefanAddress:
California, US
Priority
Number:
10170008Date:
19.7.2010Country:
EP
Classification
Categories:
G01N 33/574